Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry

Details for Australian Patent Application No. 2004238246 (hide)

Owner Schweitzer Chemical Corporation, Ltd.

Inventors Kuo, Tsun-Yung

Agent Watermark

Pub. Number AU-B-2004238246

PCT Pub. Number WO2004/100877

Priority 10/429,735 06.05.03 US

Filing date 6 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 5 April 2007

International Classifications

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/100877 Priority application(s): WO2004/100877

5 April 2007 Application Accepted

  Published as AU-B-2004238246

9 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238253-Controlled release formulation of erythromycin derivatives

2004238241-1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) - piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or TNF inhibitors for the treatment of imflammations